Skip to main content
Equibles
USPH logo

USPH · U S Physical Therapy Inc /Nv · Metrics

Track USPH — free

Use USPH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research USPH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$78.72 +1.01 (+1.30%) At close · Sep 11
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.17B
Shares
14.92M

USPH metrics

94 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$78.72
Market cap
$1.17B

Price action

20 metrics
Price change (1W)
-0.8%
Price change (30D)
-3.1%
Price change (3M)
+20.1%
Price change (6M)
+2.5%
Price change (YTD)
+0.8%
Price change (1Y)
-4.0%
Trailing year
Price change (5Y)
-30.8%
52-week high
$93.16
52-week low
$59.00
Change from 52-week high
-15.5%
Change from 52-week low
+33.4%
Annualized volatility
38.6%
Annualized volatility (3M)
31.4%
Beta
0.7
RSI (14D)
53.5
Price vs SMA 50
+2.4%
Price vs SMA 200
+4.0%
Avg volume (3M)
213,426
Relative volume
0.9
Average dollar volume
$15.91M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
14.92M

Valuation

12 metrics
P / E (TTM)
463.1
Trailing earnings · reciprocal yield 0.2%
PEG ratio
—
EV / revenue
1.7×
reciprocal yield 59.3%
EV / EBITDA
13.8×
reciprocal yield 7.2%
EV / EBIT
17.9×
reciprocal yield 5.6%
P / sales
1.4×
reciprocal yield 69.1%
P / book
2.6
reciprocal yield 38.2%
FCF yield
5.5%
TTM · current market cap
Buyback yield
2.1%
P / FCF
18.3
reciprocal yield 5.5%
P / operating cash flow
14.1
reciprocal yield 7.1%
Earnings yield
2.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.0×
reciprocal yield 48.8%
EV / revenue historical average (5Y)
2.3×
reciprocal yield 43.5%
EV / EBIT historical average (3Y)
22.1×
reciprocal yield 4.5%
EV / EBIT historical average (5Y)
21.7×
reciprocal yield 4.6%
EV / EBITDA historical average (3Y)
16.6×
reciprocal yield 6.0%
EV / EBITDA historical average (5Y)
16.9×
reciprocal yield 5.9%

Dividends & buybacks

7 metrics
Dividend yield
2.3%
Trailing 12 months
Payout ratio
—
Shareholder yield
4.5%
Dividend / share (TTM)
$1.83
Dividend growth YoY
+2.2%
Dividend growth streak
5
Last ex-dividend
2026-08-21

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
18.7%
Operating margin
9.4%
Trailing 12 months
Net margin
4.0%
Gross profit (TTM)
$151.70M
Operating profit (TTM)
$76.52M
Net income (TTM)
$32.23M
Trailing 12 months
Diluted EPS (TTM)
$0.17
FCF margin
7.9%
Effective tax rate
26.1%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$17.02

Growth

11 metrics
Revenue growth YoY
+8.5%
Year over year
Net income growth YoY
-20.1%
Revenue (TTM)
$812.20M
Trailing 12 months
EPS growth YoY
-56.9%
Shares change YoY
-0.8%
Year over year · fewer shares
Revenue CAGR (3Y)
+12.2%
Revenue CAGR (5Y)
+13.0%
EPS CAGR (3Y)
-14.2%
EPS CAGR (5Y)
-10.6%
FCF CAGR (3Y)
+6.6%
FCF CAGR (5Y)
-8.0%

Quality

14 metrics
Return on equity
7.2%
Return on assets
2.6%
Debt / equity
0.5
Current ratio
1.3
EBITDA (TTM)
$98.93M
Free cash flow (TTM)
$64.07M
Quick ratio
1.3
Interest coverage
—
Net debt / EBITDA
2.0
Return on invested capital
8.8%
Trailing 12 months
Net cash
−$195.13M
Latest balance sheet
Cash & equivalents
$24.89M
Total assets
$1.25B
Total debt
$220.02M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$83.05M
Capital expenditures (TTM)
$18.98M
R&D (TTM)
—
SG&A (TTM)
$72.82M
Stock compensation (TTM)
$9.86M
R&D / revenue
—
Stock compensation / revenue
1.2%

Ownership (13F)

3 metrics
13F filers
217
13F filer change QoQ
-12
Institutional ownership
102.8%

Short interest

3 metrics
Short interest
8.6%
Latest settlement · 8.1 days to cover
Days to cover
8.1d
Short-squeeze score
73 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 885978 CUSIP 90337L108 13F (30d) 50 filings 50 filers Visit website